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The purpose of the present study was to evaluate the effect of Ramadan fasting on insulin sensitivity in subjects with the metabolic syndrome.
Males (n 55; age 34·1 (SD 8·9) years) with the metabolic syndrome were studied. Blood pressure, waist circumference, body weight, HDL-choles-
terol (HDL-C), TAG, fasting plasma glucose (FPG), fasting blood insulin and insulin resistance indices (quantitative insulin sensitivity check index
(QUICKI), homeostasis model assessment of insulin resistance (HOMA-IR) and reciprocal index of HOMA-IR (1/HOMA-IR)) were evaluated
before and after 30 d of Ramadan fasting (two meals at 12 h intervals). The dietary intake was estimated by 24 h recall before and after fasting.
The total daily energy intake was decreased by 234·6 (SD 88·2) kJ/d in the fasting period (P¼0·005). 1/HOMA-IR, QUICKI and HDL-C were
significantly increased (P¼0·005, P¼0·001 and P¼0·004) and FPG significantly decreased (P,0·005) after fasting. Simple linear regression anal-
ysis demonstrated that HOMA-IR, 1/HOMA-IR and QUICKI were related to waist circumference after intervention (r 0·458, P,0·001; r 20·396,
P,0·05; r 20·342, P,0·05). In conclusion, the present study showed that the combined change in the number and timing of meals and portioning
of the entire intake into only two meals per d may increase insulin sensitivity in subjects with the metabolic syndrome even when the decrease in
energy consumption is minimal.
Insulin sensitivity: Ramadan fasting: Metabolic syndrome: Homeostasis model assessment: Quantitative insulin sensitivity check index
Insulin resistance is a feature of a number of clinical disorders,
including type 2 diabetes and glucose intolerance, obesity, dys-
lipidaemia and hypertension clustering in the so-called meta-
bolic syndrome(1). The prevalence of the metabolic syndrome
from the Third National Health and Nutrition Examination
Survey (NHANES III), as defined by the 2001 Adult Treatment
Panel III criteria, was 22 %, with an age-dependent increase(2)
and the prevalence has continued to increase, particularly in
women(3). Hyperinsulinaemia occurring in response to insulin
resistance may play an important role in the genesis of the meta-
bolic syndrome. Prevention or reduction of obesity, particularly
abdominal obesity, is the main therapeutic goal in patients with
the metabolic syndrome(4). Weight reduction can be optimally
achieved with a multimodality approach including diet, exer-
cise, and possible pharmacological therapy, as with orlistat(5,6).
It has been shown that many different diets such as the Mediter-
ranean diet, the dietary approach to stop hypertension (DASH)
diet, diets using foods with low glycaemic index and a low-satu-
rated fat diet may be effective in improving the metabolic
syndrome by reducing insulin resistance, independent of
weight loss(7).
Ramadan is the holiest month in the Islamic calendar and
during this month, Muslims fast every day from dawn to
sunset. They refrain from drinking and eating for this
period. The period in which the individual fasts may vary
depending on the geographic location of the country and the
season of the year and can be as long as 18 h/d in the
summer of the temperate regions. The physiological changes
induced by Ramadan fasting are not well known. It is possible
that a change in the number and timing of meals and portion-
ing the daily food intake into two (instead of the usual four or
five) could have a metabolic effect. However, conflicting
results have been reported by other studies on the effects
that this type of fasting may have on changes in blood glucose
and insulin resistance in type 2 diabetes patients and healthy
volunteers. Some studies report that this type of fasting has
beneficial effects on blood glucose and lipid profile(8,9)
while other studies have shown no change in fasting blood
glucose and lipid profile(10). There are currently no reports
on the effect of prolonged reduction of meal frequency on
lipid profile, plasma glucose and insulin resistance indices
in subjects with the metabolic syndrome. Therefore we
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conducted a study during the month of Ramadan in order to
evaluate the effects of a change in the number and timing of
meals on these metabolic outcomes.
Subjects and methods
The present study was carried out in 2006 at Doctor Lavasani
Hospital (Tehran, Iran). Male volunteers (n 62; age 34–61
years) with the metabolic syndrome were recruited. A partici-
pant was defined as having the metabolic syndrome if three or
more of the following criteria were met, according to the
National Cholesterol Education Program recommendations(11):
(1) abdominal obesity, i.e. waist circumference $90 cm (the
Caucasian criterion for abdominal obesity(12)); (2) hypertria-
cylglycerolaemia: $1500 mg/l (1·70 mmol/l); (3) low HDL-
cholesterol (HDL-C), i.e. ,1·04 mmol/l (400 mg/l); (4) high
blood pressure: $130/85 mmHg; (5) high fasting plasma glu-
cose (FPG): $1100 mg/l (6·1 mmol/l). Exclusion factors were
being female, type 2 diabetes mellitus, infections, stresses,
acromegaly, hypertension and any addiction or drug therapy.
Males were selected for the study because females are
exempt from fasting during their menstrual period. Seven sub-
jects who could not fast completely for 30 d were excluded
from the study. All subjects were encouraged to continue
their usual lifestyle and activities. The study protocol was
endorsed by the appropriate ethics committee and written
informed consent was obtained from each participant. After
a 12 h overnight fast, a fasting blood sample was taken for
determination of TAG, HDL-C, FPG and free immunoreactive
insulin (FIRI) before intervention. Plasma glucose levels were
measured by the glucose oxidase method, plasma insulin
levels by immunoradiometric assay (Insulin Riabead; Daina-
bot, Tokyo, Japan) and HDL-C by enzymic methods adapted
to an autoanalyser (Selectra; Vital Scientific, Spankeren, The
Netherlands). Homeostasis model assessment of insulin resist-
ance (HOMA-IR) and quantitative insulin sensitivity check
index (QUICKI) were assessed as surrogate indices for insulin
resistance and insulin sensitivity derived from fasting glucose
and insulin levels(13,14). QUICKI was calculated from FPG
and FIRI levels according to the report by Katz et al. (15),
with the formula QUICKI ¼ 1/(log (FIRI in mU/ml) þ log
(FPG in mg/dl)). The HOMA-IR was calculated from FPG
and FIRI according to the report by Matthews et al. (16),
with the formula HOMA-IR ¼ FIRI in mU/ml £ FPG in mg/
dl/405. Weight was measured while the subjects were mini-
mally clothed without shoes using digital scales and recorded
to the nearest 0·1 kg. Waist circumference was defined as the
minimal abdominal circumference between the xiphoid pro-
cess and the iliac crests. Dietary intake was calculated through
24 h recall. It was done for each participant before intervention
for three non-holiday, non-consecutive, non-fasting days. This
was then repeated in the fasting period. The duration of fasting
was approximately 12 h from sunrise to sunset (the time of
abstinence from food) during a 30 d period in the Northern
hemisphere autumn season. The subjects had two meals
per d; one early in the morning about 30 min before sunrise,
and the second immediately after sunset. Approximately
42 % of their intake was in the morning meal and 58 % after
sunset. At the end of this period, a 12 h overnight fasting
blood sample was taken to repeat the laboratory examinations,
and weight and waist circumference were measured.
Statistical methods
SPSS software version 12 was used to analyse data (SPSS
Inc., Chicago, IL, USA). Results are reported as mean
values and standard deviations. Paired t tests were used for
comparisons of variables before and after intervention.
Simple linear regression analysis was performed for analysis
of association among insulin resistance indices as dependent
variables with waist circumference as the independent vari-
able. For comparisons of levels of decline in insulin resistance
indices with an increase in the number of metabolic disorders
Kruskal–Wallis H test was used. For each variable, the sig-
nificance level of 0·05 for a was considered.
Results
A total of fifty-five male volunteers were included in the
study. The mean age of subjects was 34·1 (range 34–61; SD
8·9) years. Of the total, forty-nine had waist circumference
$90 cm, twenty-nine had blood pressure $130/85 mmHg,
twenty-eight had a fasting glucose $1100 mg/l (6·1 mmol/l),
thirty-nine had TAG $1500 mg/l (1·70 mmol/l) and thirty-
three had HDL ,1·04 mmol/l (400 mg/l). Clinical character-
istics and laboratory data of subjects are shown in Table 1.
The daily energy consumption during the fasting period
declined by 234·6 (SD 88·2) kJ. This decline was statistically
significant (P¼0·005). The percentages of decrease in weight
and waist circumference measurement after the trial period
were both 2·4 %. These reductions were statistically significant
(P,0·001). QUICKI was significantly higher after fasting
period (P¼0·001). HOMA-IR was not affected by Ramadan
fasting (P¼0·412) and the reciprocal index of HOMA-IR
(1/HOMA-IR) increased significantly after fasting (P¼0·005).
FPG had decreased significantly after the intervention
(P¼0·005). Fasting plasma insulin was not significantly altered
(P¼0·77).
Correlation coefficients of insulin resistance indices with
waist circumference before and after intervention are shown
in Table 2. Before and after fasting, waist circumference
was related to QUICKI, 1/HOMA-IR and HOMA-IR levels
in linear regression analysis. With decreasing waist circumfer-
ence, QUICKI and 1/HOMA-IR levels increased linearly
(QUICKI ¼ 209·63 £ waist þ 0·614, P¼0·001; 1/HOMA-
IR ¼ 22·01 £ waist þ 2·43, P¼0·02) and with decreasing
waist circumference, HOMA-IR levels decreased linearly
(HOMA-IR ¼ 0·15 £ waist 2 11·17; P¼0·007). There was
no difference in levels of decline in insulin resistance indices
with an increase in the number of metabolic disorders by the
Kruskal–Wallis test. Systolic and diastolic blood pressures
were both decreased significantly after the fasting period
(P,0·001) and the increase in HDL-C levels after the inter-
vention was also significant (P¼0·004). Level of serum
TAG increased after fasting, although its rising was not sig-
nificant (P¼0·216).
Discussion
The results of the present study demonstrate that Ramadan
fasting can lead to some beneficial changes in FPG, HDL,
insulin sensitivity and blood pressure in the metabolic syn-
drome. QUICKI and 1/HOMA-IR were increased significantly
Z. Vahdat Shariatpanahi et al.148
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after fasting but there was no significant decline in HOMA-IR;
this may be because HOMA-IR does not adequately predict
insulin resistance in all individuals. Indeed, several investi-
gators have reported that HOMA-IR does not correlate
highly or significantly with insulin resistance, particularly in
individuals with impaired glucose tolerance(17 – 20). There
was a linear increase in QUICKI and 1/HOMA-IR levels
with a decreasing waist circumference. Also there was a
linear decrease in HOMA-IR level with a decreasing waist cir-
cumference. Studies indicate that visceral obesity is highly
correlated with insulin resistance(21). The mean decline in
energy consumption by our subjects was 234·6 (SD 88·2)
kJ/d, corresponding to a mean weight reduction of 1·96
(SD 1·35) kg in the period of intervention. We had expected
that, with this amount of decrease in daily energy consumption
for 1 month, weight reduction would be about 300 g. These
changes may be due to omitting the midday meal when the
body is particularly active metabolically. Fasting during the
month of Ramadan is a unique metabolic model that includes
abstinence from food and fluid intakes as well as from sexual
activity during the period from dawn to sunset. It seems that a
change in the number and timing of meals and portioning the
entire intake into two (instead of the usual four or five) could
have an effect on patients with the metabolic syndrome. It has
been established that a given nutrient ingested at an unusual
time can induce different metabolic effects(22). During Rama-
dan fasting the sleep–wakefulness cycle is also altered. This
leads to changes in levels of leptin, neuropeptide-Y and insu-
lin that play an important role in the long-term regulation of
energy intake and energy expenditure(23). Also it has been
shown that modifications in sleep schedules and psychological
and social habits during Ramadan induce changes in the rhyth-
mic pattern of a number of hormonal variables, i.e. melatonin,
steroid hormones (cortisol, testosterone), pituitary hormones
(prolactin, luteinising hormone, follicular stimulating hor-
mone, growth hormone and thyroid-stimulating hormone)
and thyroid hormones(24). These hormones are related to
energy metabolism and the regulation of energy intake. Sig-
nificant changes in the proportions of dietary fats (215 %)
and carbohydrates (þ6 %) as shown in Table 1 may also con-
tribute to the observed effect on insulin resistance. Unfortu-
nately there is no study to determine the effect of this type
of fasting on the metabolic syndrome. Ziaee et al. showed
that Ramadan fasting led to a decrease in fasting blood glu-
cose and weight in healthy volunteers. Although there was a
significant reduction in meal frequency, a significant increase
in LDL and decrease in HDL was noted during Ramadan.
Unfortunately, no data were reported about the levels of
energy intake of the patients before and during Ramadan in
their study(8). Larijani et al. showed that fasting blood glucose
decreases with Ramadan fasting in healthy volunteers and was
positively correlated with decreased energy intake in this
period(9). Bouguerra et al. assessed the effect of fasting
during Ramadan on the metabolic profile of patients with
type 2 diabetes. They concluded that Ramadan fasting
causes a slight effect on glycaemia and lipoprotein levels
when previous metabolic control is quite good, but fasting
induces more deterioration when previous control is poor.
One limitation of this study is that there are no data
about energy consumption. The subjects consisted of both
men and women; 30 % of the patients were treated with oral
Table 1. Clinical and laboratory characteristics of the subjects before and after fasting
(Mean values and standard deviations)
Before fasting After fasting
Mean SD Mean SD P
Systolic blood pressure (mmHg) 115·00 13·57 108·93 11·57 ,0·001
Diastolic pressure (mmHg) 76·66 7·97 73·78 6·46 ,0·001
Waist (cm) 94·81 7·80 91·98 7·70 ,0·001
Weight (kg) 80·69 12·27 78·73 12·05 ,0·001
BMI (kg/m2) 27·62 3·39 26·87 3·36 ,0·001
Total energy (kJ) 12 595 802·56 12 361 661·38 0·005
Protein (g) 75·14 5·62 73·82 3·95 0·030
Carbohydrate (g) 402·99 25·62 428·18 22·95 ,0·001
Fat (g) 122·27 8·40 104·99 5·62 ,0·001
HDL-cholesterol (mg/l) 428·7 54·5 462·4 55·0 0·004
TAG (mg/l) 2100 1396·0 2327·8 1088·7 0·216
FPG (mg/l) 894·5 287·9 812·1 178·4 0·005
FIRI (mU/ml) 14·72 21·75 13·74 9·47 0·770
QUICKI 0·5161 0·02 0·5253 0·02 0·001
HOMA-IR 3·73 6·26 2·94 2·58 0·412
1/HOMA-IR 0·5864 0·66 0·8427 0·38 0·005
FPG, fasting plasma glucose; FIRI, free immunoreactive insulin; QUICKI, quantitative insulin sensitivity check
index; HOMA-IR, homeostasis model assessment of insulin resistance; 1/HOMA-IR, reciprocal index of homeo-
stasis model assessment of insulin resistance.
Table 2. Correlation coefficients of insulin resistance indices with waist
circumference before and after fasting period
Waist before fasting period Waist after fasting period
QUICKI 20·390*** 20·342***
HOMA-IR 0·371*** 0·458**
1/HOMA-IR 20·600* 20·396***
QUICKI, quantitative insulin sensitivity check index; HOMA-IR, homeostasis model
assessment of insulin resistance; 1/HOMA-IR, reciprocal index of homeostasis
model assessment of insulin resistance.
*P,0.001, **P,0.01, ***P,0.05.
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hypoglycaemic agents while three patients were treated
through diet(10). Yarahmadi et al. evaluated the effects of
Ramadan fasting on anthropometric indices and carbohydrate
and lipid metabolism in both men and women with type 2 dia-
betes. They found that plasma insulin, C-peptide and insulin
resistance decreased significantly only in men. They con-
cluded that Ramadan fasting does not alter carbohydrate
metabolism or tissue insulin sensitivity in patients with type
2 diabetes(25). Again a limitation of this study is that there
are no data about energy intake and also the results were
focused on both female and male subjects.
A limitation of the present study is that the level of
physical activity was not measured. Although we encouraged
the subjects to continue their usual physical activities, one can
suspect that as a result of limiting food intake, physical activi-
ties tend to decrease during the month of Ramadan fasting.
In conclusion, the present study has demonstrated that a
change in the number and timing of meals and portioning of
the entire daily intake into two meals may increase insulin
sensitivity in the metabolic syndrome. Therefore, Ramadan
fasting provides an excellent opportunity to study the effects
of the prolonged reduction of meal frequency on body metab-
olism such as insulin sensitivity.
Acknowledgements
Our thanks go to the health deputy of the Social Security
Organization, Doctor Lavasani Hospital, Alavi School and
all those who contributed to the study for their valuable help
and support. The source of funding for our research is the
health deputy of the Social Security Organization. There are
no conflicts of interest. The contribution of authors to the pre-
sent study was: M. V. S. for the design of the experiment; S. S.
for the provision of significant advice and consultation; Z. V. S.
for the writing of the manuscript and consultation; A. H. for
the collection of data; A. A. for the analysis of data.
References
1. Sesti G (2006) Pathophysiology of insulin resistance. Best Pract
Res Clin Endocrinol Metab 20, 665–679.
2. Ford ES, Giles WH & Dietz WH (2002) Prevalence of the meta-
bolic syndrome among US adults: findings from the third
National Health and Nutrition Examination Survey. JAMA
287, 356–359.
3. Ford ES, Giles WH & Mokdad AH (2004) Increasing preva-
lence of the metabolic syndrome among U.S. adults. Diabetes
Care 27, 2444–2449.
4. Manson JE, Skerrett PJ, Greenland P & VanItallie TB (2004) The
escalating pandemics of obesity and sedentary lifestyle. A call to
action for clinicians. Arch Intern Med 164, 249–258.
5. Heymsfield SB, Segal KR, Hauptman J, Lucas CP, Boldrin MN,
Rissanen A, Wilding JP & Sjo¨stro¨m L (2000) Effects of
weight loss with orlistat on glucose tolerance and progression
to type 2 diabetes in obese adults. Arch Intern Med 160,
1321–1326.
6. Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F,
Giugliano G, D’Armiento M, D’Andrea F & Giugliano D
(2004) Effect of a Mediterranean-style diet on endothelial dys-
function and markers of vascular inflammation in the metabolic
syndrome: a randomized trial. JAMA 292, 1440–1446.
7. Minehira K & Tappy L (2002) Dietary and lifestyle interven-
tions in the management of the metabolic syndrome: present
status and future perspective. Eur J Clin Nutr 56, 1264–1269.
8. Ziaee V, Razaei M, Ahmadinejad Z, Shaikh H, Yousefi R,
Yarmohammadi L, Bozorgi F & Behjati MJ (2006) The changes
of metabolic profile and weight during Ramadan fasting. Singapore
Med J 47, 409–414.
9. Larijani B, Zahedi F, Sanjari M, Amini MR, Jalili RB, Adibi
H & Vassigh AR (2003) The effect of Ramadan fasting on
fasting serum glucose in healthy adults. Med J Malaysia 58,
678–680.
10. Bouguerra R, Jabrane J, Maatki C, Ben Salem L, Hamzaoui J,
El Kadhi A, Ben Rayana C & Ben Slama C (2006) Ramadan
fasting in type 2 diabetes mellitus. Ann Endocrinol 67,
54–59.
11. Expert Panel on Detection, Evaluation, and Treatment of High
Blood Cholesterol in Adults (2001) Executive Summary of the
Third Report of the National Cholesterol Education Program
(NCEP) Expert Panel on Detection, Evaluation, and Treatment of
High Blood Cholesterol in Adults (Adult Treatment Panel III).
JAMA 285, 2486–2497.
12. Inoue S, Zimmet P, Caterson I, Chunming C, Ikeda Y, Khalid
AK, Kim YS & Bassett J (2000) The Asia-Pacific perspective:
Redefining Obesity and its Treatment. Canberra, Australia:
Health Communications Australia Pty Limited. http://www.
diabetes.com.au/pdf/obesity_report.pdf
13. Chen H, Sullivan G & Quon MJ (2005) Assessing the predictive
accuracy of QUICKI as a surrogate index for insulin sensitivity
using a calibration model. Diabetes 54, 1914–1925.
14. Yokoyama H, Emoto M, Fujiwara S, Motoyama K, Morioka T,
Komatsu M, Tahara H, Shoji T, Okuno Y & Nishizawa Y
(2003) Quantitative insulin sensitivity check index and the reci-
procal index of homeostasis model assessment in normal range
weight and moderately obese type 2 diabetic patients. Diabetes
Care 26, 2426–2432.
15. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA,
Sullivan G & Quon MJ (2000) Quantitative insulin sensiti-
vity check index: a simple, accurate method for assessing
insulin sensitivity in humans. J Clin Endocrinol Metab 85,
2402–2410.
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF
& Turner RC (1985) Homeostasis model assessment: insulin
resistance and b-cell function from fasting plasma glucose and
insulin concentrations in man. Diabetologia 28, 412–419.
17. Ferrara CM & Goldberg AP (2001) Limited value of the homeo-
stasis model assessment to predict insulin resistance in older
men with impaired glucose tolerance. Diabetes Care 24,
245–249.
18. Anderson RL, Hamman RF, Savage PJ, Saad MF, Laws A,
Kades WW, Sands RE & Cefalu W (1995) Exploration of
simple insulin sensitivity measures derived from frequently
sampled intravenous glucose tolerance (FSIGT) tests. Am J Epi-
demiol 142, 724–732.
19. Saad MF, Anderson RL, Laws A, Watanabe RM, Kades WW,
Chen Y-D, Sands RE, Pei D, Savage PJ & Bergman RN (1994)
A comparison between the minimal model and the glucose
clamp in the assessment of insulin sensitivity across the spectrum
of glucose tolerance. Diabetes 43, 1114–1121.
20. Yeni-Komshian H, Carantoni M, Abbasi F & Reaven GM
(2000) Relationship between several surrogate estimates of insu-
lin resistance and quantification of insulin-mediated glucose dis-
posal in 490 healthy nondiabetic volunteers. Diabetes Care 23,
171–175.
21. Richelsen B & Pedersen SB (1995) Associations between differ-
ent anthropometric measurements of fatness and metabolic risk
parameters in non-obese, healthy, middle-aged men. Int J Obes
Relat Metab Disord 19, 169–174.
Z. Vahdat Shariatpanahi et al.150
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
D
ow
nloaded from
 https://w
w
w
.cam
bridge.org/core . IP address: 5.114.96.92 , on 04 A
ug 2020 at 15:38:26 , subject to the C
am
bridge C
ore term
s of use, available at https://w
w
w
.cam
bridge.org/core/term
s . https://doi.org/10.1017/S000711450787231X
22. Nelson W, Cadotte L & Halberg F (1973) Circadian timing of
single daily meal affects survival of mice. Proc Soc Exp Biol
Med 144, 766–769.
23. Kassab S, Abdul-Ghaffar T, Nagalla DS, Sachdeva U & Nayar U
(2004) Interactions between leptin, neuropeptide-Y and insulin
with chronic diurnal fasting during Ramadan. Ann Saudi Med
24, 345–349.
24. Bogdan A, Bouchareb B & Touitou Y (2001) Ramadan fasting
alters endocrine and neuroendocrine circadian patterns. Meal-
time as a synchronizer in humans? Life Sci 68, 1607–1615.
25. Yarahmadi SH, Larijani B, Bastanhagh MH, Pajouhi M,
Baradar Jalili R, Zahedi F, Zendehdel K & Akrami SM (2003)
Metabolic and clinical effects of Ramadan fasting in patients with
type II diabetes. J Coll Physicians Surg Pak 13, 329–332.
Effect of fasting on insulin resistance 151
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
D
ow
nloaded from
 https://w
w
w
.cam
bridge.org/core . IP address: 5.114.96.92 , on 04 A
ug 2020 at 15:38:26 , subject to the C
am
bridge C
ore term
s of use, available at https://w
w
w
.cam
bridge.org/core/term
s . https://doi.org/10.1017/S000711450787231X
